Relmada Therapeutics is a late-stage biotechnology company addressing diseases of the central nervous system (CNS) and metabolic disorders. Relmada’s experienced and dedicated team is committed to ...
PRINCETON, N.J., Dec. 09, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery ...
WILMINGTON, DE, UNITED STATES, December 9, 2024 /EINPresswire / -- The Europe beer market size was valued at $138,649 million in 2017, and is projected to reach $159,687 million by 2025, registering a ...
Silence Therapeutics plc ("Silence" or the "Company") , a global clinical-stage company developing novel siRNA (short interfering RNA) therapies, today announced additional results from the Phase 1 ...